Medicine worth paying for : assessing medical innovations
著者
書誌事項
Medicine worth paying for : assessing medical innovations
Harvard University Press, 1995
大学図書館所蔵 全8件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references (p. [283]-300) and index
内容説明・目次
内容説明
How is medicine doing at the end of the twentieth century? While there has been no end of studies of our health care system and proposals for changing it, there have been few credible studies of the risks and benefits of widely used medical treatments. We simply do not always know whether one treatment is better than another or whether a particular drug is worth the price.
Medical technology assessment is the discipline that studies what does and does not work in medicine. Howard Frazier and Frederick Mosteller are leading figures in this field. In Medicine Worth Paying For they attempt something completely new: to distill the methods and knowledge base of their highly specialized discipline into a text that is accessible-and therefore of great value-to a nontechnical audience.
This book calls attention to the importance of technology assessment in medicine-the rigorous evaluation of the effects of medical treatments-with particular reference to medical innovations. Also, making use of a series of carefully selected cases, the authors identify important policy implications that can be drawn from the study of successful medical innovations. These case studies of medical successes are a rich source of examples of the effects, good and bad, of the application of technology to health care and of attempts to influence the diffusion of technologies in health care.
Medicine Worth Paying For should be of interest to a variety of readers, particularly those concerned with health policy, investigators studying health services, those in the health professions, nonprofessionals who wish to maintain and improve the performance of the health care system, and others who simply want a system that provides benefits greater than risks at an acceptable financial cost.
目次
- Part 1 Background: the nature of inquiry, Howard S. Frazier and Frederick Mosteller
- evaluating medical technologies, Frederick Mosteller and Howard S. Frazier. Part 2 Physician performance: laparoscopic cholecystectomy for gallstones, Leon D. Goldman
- preserving vision in diabetic retinopathy - the impact of laser treatment, Michael R. Albert and Daniel M. Albert
- the treatment of unipolar depression, Howard S. Frazier. Part 3 Perverse financial incentives: kidney transplantation, Miriam E. Adams
- epoetin therapy for renal anemia - health policy and quality-of-life perspectives, Jennifer F. Taylor. Part 4 Patient empowerment: the control of postoperative pain, Jane C. Ballantyne et al. Part 5 Monitoring and delivering care: immunization against measles, Donald N. Medearis, Jr
- treatment of hypertension, Sidney Klawansky. Part 6 The delivery of routine care - visual and dental health: the contributions of lenses to visual health, Georgianna Marks et al
- dentistry, Alexia Antczak-Bouckoms and J.F.C. Tulloch. Part 7 Quality of life and cost-effectiveness: total joint replacement for the treatment of osteoarthritis, Jennifer F. Taylor and Elisabeth Burdick. Part 8 Unanticipated effects of treatment: peptic ulcer, Thomas C. Chalmers
- oral contraceptives - post-marketing surveillance and rare, late complications of drugs, Howard S. Frazier and Graham A. Colditz. Part 9 Administrative innovations: surgery and anesthesiology, Debra R. Milamed and John Hedley-Whyte. Part 10 Conclusions and recommendations: improving the health care system, Frederick Mosteller and Howard S. Frazier
- innovation-specific improvements, Frederick Mosteller and Howard S. Frazier
- recommendations for change, Howard S. Frazier and Frederick Mosteller.
「Nielsen BookData」 より